Dare Bioscience (DARE) Other Working Capital Changes (2016 - 2025)
Dare Bioscience's (DARE) quarterly Other Working Capital Changes came in at -$143406.0 in Q4 2025, down 42.56% YoY from -$249671.1 in Q4 2024, and down 3.25% on a QoQ basis from -$138894.0 in Q3 2025.
Dare Bioscience (DARE) Other Working Capital Changes (2016 - 2025) Analysis & Trends
Dare Bioscience (DARE) has 4 years of Other Working Capital Changes data on file, last reported at -$143406.0 in Q4 2025.
- Quarterly Other Working Capital Changes fell 42.56% year-over-year to -$143406.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$548638.0 (down 19.33% YoY) and the FY2025 annual result came in at -$548638.0, down 19.33% from the prior year.
- Other Working Capital Changes eased to -$143406.0 in Q4 2025, from -$138894.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $559279.0 in Q3 2023 to a low of -$1.1 million in Q4 2025.
- A 4-year average of -$42817.0 and a median of $70715.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes slumped 108.31% — and 2025, when it declined 8.8%.
- Tracing DARE's Other Working Capital Changes over 3 years: stood at $1.2 million in 2023, then sank by 108.31% to -$100592.0 in 2024, then slumped by 42.56% to -$143406.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$143406.0 (Q4 2025), -$138894.0 (Q3 2025), and -$134909.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Dare Bioscience | 11.91 Mn | -705,728.22 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.05 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Jun 30, 2024 | -152,204.00 |
| Jun 30, 2024 | -152,204.00 |
| Jun 30, 2024 | -152,204.00 |
| Mar 31, 2024 | 152,204.00 |
| Mar 31, 2024 | 152,204.00 |
| Mar 31, 2024 | 152,204.00 |
| Sep 30, 2023 | 559,279.00 |
| Sep 30, 2023 | 559,279.00 |
| Sep 30, 2023 | 559,279.00 |
| Jun 30, 2023 | 70,715.00 |
| Jun 30, 2023 | 70,715.00 |
| Jun 30, 2023 | 70,715.00 |
| Mar 31, 2023 | 201,385.00 |
| Mar 31, 2023 | 201,385.00 |
| Mar 31, 2023 | 201,385.00 |
| Sep 30, 2022 | -77,939.00 |
| Sep 30, 2022 | -77,939.00 |